Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: Dave who wrote (231)	3/14/2001 4:28:29 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 370

Dave, beyond the statments I have already made there is not much else for me to add. Your best bet is to call or email IR at Vion and ask them! Yes, cash is a concern a year from now. Lots of test results will be available in a year. Vion has multiple drugs in testing. Perhaps they will not try and bring all of them to trials at once to save money. I believe the two month delay in the start of the lastest trial may be an indication that this is a concern. While the market in general has certainly soured, I content that with the good test results, Vion will be able to raise capital one way or another. Jim